AI-assisted, human-published
10/21/2025 /Funding Events
PleoPharma Secures $36MM Funding to Advance Cannabis Withdrawal Treatment
PleoPharma, Inc. closes a $36 million Series B funding round to advance PP-01, the first Fast Track-designated treatment for Cannabis Withdrawal, aiming to deliver first-in-class treatments for cannabis addiction and withdrawal.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com